PLX vs RNA
Comparison between Protalix BioTherapeutics Inc (PLX, Company) and Atrium Therapeutics Inc (RNA, Company).
Both PLX and RNA are from the Healthcare sector.
PLX vs RNA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PLX
$209M
RNA
$208M
Max Drawdown
PLX
99.85%
Winner
RNA
32.41%
Sharpe Ratio
Winner
PLX
0.83
RNA
-0.75
5Y Beta
Winner
PLX
0.79
RNA
0.89
Industry
PLX
Biotechnology
RNA
Biotechnology
P/E Ratio
PLX
8.48
RNA
N/A
Forward P/E
PLX
12.72
RNA
N/A
PEG Ratio
Winner
PLX
-0.10
RNA
0.00
Debt to Equity
PLX
0.00%
RNA
0.00%
Free Cash Flow Yield
Winner
PLX
3.67%
RNA
0.00%
P/S Ratio
Winner
PLX
2.76
RNA
5.68
P/B Ratio
PLX
2.97
Winner
RNA
0.89
PLX vs RNA - Historical Returns
Returns include dividend reinvestment.
1M
PLX
-1.46%
Winner
RNA
+0.90%
3M
Winner
PLX
+22.02%
RNA
-7.29%
6M
PLX
-20.71%
Winner
RNA
-16.41%
1Y
PLX
+46.27%
RNA
N/A
5Y(CAGR)
PLX
+11.94%
RNA
N/A
10Y(CAGR)
PLX
-9.30%
RNA
N/A
Max(CAGR)
Winner
PLX
-13.06%
RNA
-32.43%
PLX vs RNA - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | PLX | RNA |
|---|---|---|
| 2026 | +35.34% | -16.41% |
| 2025 | -8.63% | N/A |
| 2024 | +3.30% | N/A |
| 2023 | +29.93% | N/A |
| 2022 | +50.55% | N/A |
| 2021 | -76.77% | N/A |
| 2020 | +1.97% | N/A |
| 2019 | -3.53% | N/A |
| 2018 | -55.18% | N/A |
| 2017 | +59.21% | N/A |
| 2016 | -55.94% | N/A |
| 2015 | -45.45% | N/A |
| 2014 | -53.54% | N/A |
| 2013 | -27.96% | N/A |
| 2012 | +3.80% | N/A |
| 2011 | -52.64% | N/A |
| 2010 | +44.64% | N/A |
| 2009 | +257.84% | N/A |
| 2008 | -46.82% | N/A |
| 2007 | -87.48% | N/A |
| 2006 | -58.87% | N/A |
| 2005 | +2025.00% | N/A |
| 2004 | -50.00% | N/A |
| 2003 | +263.64% | N/A |
| 2002 | -52.17% | N/A |
| 2001 | +22.99% | N/A |
| 2000 | -78.75% | N/A |
| 1999 | -12.50% | N/A |
PLX vs RNA Drawdown Comparison
The maximum drawdown for PLX was -99.85%, occurring on Jan 27, 2022. This drawdown has not yet recovered.
The maximum drawdown for RNA was -32.41%, occurring on Jul 29, 2026. This drawdown has not yet recovered.
The current PLX drawdown is -99.56%. The current RNA drawdown is -25.45%.
| Rank | PLX | RNA |
|---|---|---|
| #1 | -99.85% Jun 14, 2006 - Jan 27, 2022 | -32.41% Mar 4, 2026 - Jul 29, 2026 |
| #2 | -94.34% Nov 2, 1999 - Dec 7, 2005 | N/A |
| #3 | -31.51% Dec 12, 2005 - Jun 14, 2006 | N/A |
Correlation
Correlation between PLX and RNA is 0.52 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.52
-101
Select Stocks to Compare
Popular: PLX vs SPYRNA vs SPY
More Comparisons
Compare with similar stocks